Cardiac and vascular changes in elderly atherosclerotic mice: The influence of gender

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Pereira, Thiago M C ^a   Nogueira, Breno V ^a   Lima, Leandro C F ^a   Porto, Marcella L ^a   Arruda, Jose A ^a   Vasquez, Elisardo C ^a   Meyrelles, Silvana S ^a  

^a Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL;

AGED; AGING; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA VALVE REGURGITATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEART SIZE; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MALE; MOUSE; NONHUMAN; SENESCENCE; SEX DIFFERENCE; WATER CONTENT; ANIMAL; AORTA; AORTA DISEASE; AORTA VALVE; BLOOD; C57BL MOUSE; DISEASE COURSE; GENETICS; HOSPITALIZATION; LIPID METABOLISM; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; RANDOMIZATION; SEXUAL DEVELOPMENT;

MUS;

AGING; ANGIOGRAPHY; ANIMALS; AORTA; AORTIC DISEASES; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DISEASE PROGRESSION; FEMALE; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RANDOM ALLOCATION; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 77955682572     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-87     Document Type: Article

References (49)

1. Cardiac Morphology and function in senescent rats: gender-related differences. DE Forman A Cittadini G Azhar PS Douglas JY Wei, J Am Coll Cardiol 1997 30 1872 1877 10.1016/S0735-1097(97)00411-7 9385921
2. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. EG Lakatta D Levy, Circulation 2003 107 139 146 10.1161/01.CIR.0000048892.83521. 58 12515756 (Pubitemid 36070946)
3. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. LJ Shaw CN Bairey Merz CJ Pepine SE Reis V Bittner SF Kelsey M Olson BD Johnson S Mankad BL Sharaf WJ Rogers TR Wessel CB Arant GM Pohost A Lerman AA Quyyumi G Sopko Investigators WISE, J Am Coll Cardiol 2006 47 3 Suppl 4 S20 10.1016/j.jacc.2005. 01.072 16458170
4. Androgen therapy and atherosclerotic cardiovascular disease. KC McGrath LS McRobb AK Heather, Vasc Health Risk Manag 2008 4 11 21 10.2147/vhrm.2008.04. 01.11 18629352
5. Testosterone and atherosclerosis. A Eckardstein FC Wu, Growth Horm IGF Res 2003 13 suppl A 72 84 10.1016/S1096-6374(03)00059-5 12914731
6. Valvular heart disease: focus on women. CM Otto, Cardiol Rev 2007 15 291 297 10.1097/CRD.0b013e318156a798 18090064
7. Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. BV Nogueira VA Peotta SS Meyrelles EC Vasquez, Arch Med Res 2007 38 816 821 10.1016/j.arcmed.2007.06.005 17923260
8. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. E Aikawa M Nahrendorf D Sosnovik VM Lok FA Jaffer M Aikawa R Weissleder, Circulation 2007 115 377 386 10.1161/CIRCULATIONAHA.106.654913 17224478
9. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. AS Plump JD Smith T Hayek K Aalto-Setälä A Walsh JG Verstuyft EM Rubin JL Breslow, Cell 1992 71 343 353 10.1016/0092-8674(92)90362-G 1423598
10. Mouse models of experimental atherosclerosis. J Javie P Nastalek R Korbut, J Physiol Pharmacol 2004 55 503 517 15381823
11. Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. RM Arruda VA Peotta SS Meyrelles EC Vasquez, Hypertension 2005 46 932 936 10.1161/01.HYP.0000182154. 61862.52 16087779
12. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. PA Bourassa PM Milos BJ Gaynor JL Breslow RJ Aiello, Proc Natl Acad Sci USA 1996 93 10022 10027 10.1073/pnas.93.19.10022 8816744
13. Androgen-Induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels. L McRobb DJ Handelsman AK Heather, Endocrinology 2009 150 841 848 10.1210/en.2008-0760 19176322
14. G Pujadas, Coronary Angiography in the Medical and Surgical Treatment of Ischemic Heart Disease New York: McGraw-Hill Book Company 1980
15. Swim training attenuates myocardial remodeling and the pulmonary congestion in wistar rats with secondary heart failure to myocardial infarction. LA Portes PJ Tucci, Arq Bras Cardiol 2006 87 54 59 10.1590/S0066- 782X2006001400008 16906270
16. Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. T Minamino T Yoshida K Tateno H Miyauchi Y Zou H Toko I Komuro, Circulation 2003 108 2264 2269 10.1161/01.CIR.0000093274.82929.22 14557365
17. Echocardiographic and histological assessment of age-related valvular changes in normal rats. S Droogmans B Roosens B Cosyns S Hernot C Weytjens C Degaillier C Garbar V Caveliers M Pipeleers-Marichal PR Franken A Bossuyt T Lahoutte D Schoors G Van Camp, Ultrasound Med Biol 2009 35 558 565 10.1016/j.ultrasmedbio.2008.10.006 19111968
18. Images in cardiovascular medicine. mouse coronary angiograph using synchrotron radiation microangiography. T Yamashita S Kawashima M Ozaki M Namiki T Hirase N Inoue K Hirata K Umetani K Sugimura M Yokoyama, Circulation 2002 105 3 4 10.1161/hc0202.100423 11790712
19. Use of pulse wave and color flow Doppler echocardiography in mouse models of human disease. RD Patten MJ Aronovitz P Bridgman NG Pandian, J Am Soc Echocardiogr 2002 15 708 714 10.1067/mje.2002.118912 12094169
20. Endocardial myxomatous change in Harlan Sprague-Dawley rats (Hsd:S-D) and CD-1 mice: its microscopic resemblance to drug-induced valvulopathy in humans. CS Elangbam KA Colman RM Lightfoot RD Tyler HG Wall, Toxicol Pathol 2002 30 483 491 12187939
21. Age-associated aortic stenosis in apolipoprotein E-deficient mice. K Tanaka M Sata D Fukuda Y Suematsu N Motomura S Takamoto Y Hirata R Nagai, J Am Coll Cardiol 2005 46 134 141 10.1016/j.jacc.2005.03.058 15992647
22. Vascular actions of estrogens: functional implications. VM Miller SP Duckles, Pharmacol Rev 2008 60 210 241 10.1124/pr.107.08002 18579753
23. In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology. S Droogmans PR Franken C Garbar C Weytjens B Cosyns T Lahoutte V Caveliers M Pipeleers-Marichal A Bossuyt D Schoors G Van Camp, Eur Heart J 2007 28 2156 2162 10.1093/eurheartj/ehm263 17636306
24. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. JE Cosmi S Kort PA Tunick BP Rosenzweig RS Freedberg ES Katz RM Applebaum I Kronzon, Arch Intern Med 2002 162 2345 2347 10.1001/archinte.162.20.2345 12418948
25. Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice. K Hanada M Vermeij GA Garinis MC de Waard MG Kunen L Myers A Maas DJ Duncker C Meijers HC Dietz R Kanaar J Essers, Circ Res 2007 100 738 746 10.1161/01.RES.0000260181.19449.95 17293478
26. Genetic disruption of angiotensin II type 1a receptor improves long-term survival of mice with chronic severe aortic regurgitation. M Nakanishi M Harada I Kishimoto K Kuwahara R Kawakami Y Nakagawa S Yasuno S Usami H Kinoshita Y Adachi A Fukamizu Y Saito K Nakao, Circ J 2007 71 1310 1316 10.1253/circj.71. 1310 17652901
27. Effectiveness of beta-blockade in experimental chronic aortic regurgitation. E Plante D Lachance M Gaudreau MC Drolet E Roussel M Arsenault J Couet, Circulation 2004 110 1477 1483 10.1161/01.CIR.0000141733.55236.9D 15353507
28. Optimizing dosage of ketamine and xylazine in murine echocardiography. Q Xu Z Ming AM Dart XJ Du, Clin Exp Pharmacol Physiol 2007 34 499 507 10.1111/j.1440-1681.2007.04601.x 17439422
29. Impact of anesthesia on valvular function in normal rats during echocardiography. S Droogmans R Lauwers B Cosyns B Roosens PR Franken C Weytjens A Bossuyt T Lahoutte D Schoors G Van Camp, Ultrasound Med Biol 2008 34 1564 1572 10.1016/j.ultrasmedbio.2008.02.017 18455290
30. Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. CY Hart JC Burnett Jr MM Redfield, Am J Physiol Heart Circ Physiol 2001 281 1938 1945 11668054
31. Hypercholesterolemic valvulopathy: an aspect of malignant atherosclerosis. A Kawaguchi C Yutani A Yamamoto, Ther Apher Dial 2003 7 439 443 10.1046/j.1526-0968.2003.00075.x 12887729
32. Valvular heart disease: aortic regurgitation. R Bekeredjian PA Grayburn, Circulation 2005 112 125 134 10.1161/CIRCULATIONAHA.104.488825 15998697
33. Compensatory enlargement of human atherosclerotic coronary arteries. S Glagov E Weisenberg CK Zarins R Stankunavicius GJ Kolettis, N Engl J Med 1987 316 1371 1375 10.1056/NEJM198705283162204 3574413 (Pubitemid 17079680)
34. Arterial remodeling: relation to hemodynamics. BL Langille, Can J Physiol Pharmacol 1996 74 834 841 10.1139/cjpp-74-7-834 8946070
35. Compensatory enlargement and stenosis develop in apoE(-/-) and apoE*3-Leiden transgenic mice. E Lutgens ED de Muinck S Heeneman MJ Daemen, Arterioscler Thromb Vasc Biol 2001 21 1359 1365 10.1161/hq0801.093669 11498466
36. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. KS Meir E Leitersdorf, Arterioscler Thromb Vasc Biol 2004 24 1006 1014 10.1161/01.ATV.0000128849.12617.f4 15087308
37. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. S Bonthu DD Heistad DA Chappell KG Lamping FM Faraci, Arterioscler Thromb Vasc Biol 1997 17 2333 2340 9409199
38. Expansive remodeling is a response of the plaque-related vessel wall in aortic roots of apoE-deficient mice: an experiment of nature. JF Bentzon G Pasterkamp E Falk, Arterioscler Thromb Vasc Biol 2003 23 257 262 10.1161/01.ATV.0000051387.70962.79 12588768
39. Principles of vascular remodeling. S Glagov C Ko HS Bassiouny CK Zarins, Panvascular Medicine Berlin: Springer-Verlag, Lanzer P, Topol EJ, 2002 232 241
40. Imaging of atherosclerosis. Remodelling of coronary arteries. G Pasterkamp PC Smits, J Cardiovasc Risk 2002 9 229 235 10.1097/00043798- 200210000-00002 12394315
41. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. T Kunieda T Minamino J Nishi K Tateno T Oyama T Katsuno H Miyauchi M Orimo S Okada M Takamura T Nagai S Kaneko I Komuro, Circulation 2006 114 953 960 10.1161/CIRCULATIONAHA.106.626606 16908765
42. Vascular cell senescence: contribution to atherosclerosis. T Minamino I Komuro, Circ Res 2007 100 15 26 10.1161/01.RES.0000256837.40544.4a 17204661
43. Aging decreases the production of PGI2 in rat aortic endothelial cells. M Nakajima M Hashimoto F Wang K Yamanaga N Nakamura T Uchida K Yamanouchi, Exp Gerontol 1997 32 685 693 10.1016/S0531-5565(97)00089-2 9785094
44. eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. H Matsushita E Chang AJ Glassford JP Cooke CP Chiu PS Tsao, Circ Res 2001 89 793 798 10.1161/hh2101.098443 11679409
45. Telomere length and replicative aging in human vascular tissues. E Chang CB Harley, Proc Natl Acad Sci USA 1995 92 11190 11194 10.1073/pnas.92.24.11190 7479963
46. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. JD Erusalimsky DJ Kurz, Exp Gerontol 2005 40 634 642 10.1016/j.exger.2005.04.010 15970413
47. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. H Hamada MK Kim A Iwakura M Ii T Thorne G Qin J Asai Y Tsutsumi H Sekiguchi M Silver A Wecker E Bord Y Zhu R Kishore DW Losordo, Circulation 2006 114 2261 2270 10.1161/CIRCULATIONAHA.106.631465 17088460
48. Telomere length and possible link to X chromosome. TS Nawrot JA Staessen JP Gardner A Aviv, Lancet 2004 363 507 510 10.1016/S0140-6736(04)15535-9 14975611
49. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. C Matthews I Gorenne S Scott N Figg P Kirkpatrick A Ritchie M Goddard M Bennett, Circ Res 2006 99 156 164 10.1161/01.RES.0000233315.38086.bc 16794190